Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 38 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

18%

7 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

15 recruiting

Enrollment Performance

Analytics

N/A
16(50.0%)
Phase 2
8(25.0%)
Phase 4
4(12.5%)
Phase 3
3(9.4%)
Phase 1
1(3.1%)
32Total
N/A(16)
Phase 2(8)
Phase 4(4)
Phase 3(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (38)

Showing 20 of 38 trials
NCT07795723Not ApplicableRecruiting

Ipsilateral Versus Bilateral Systematic Biopsy Combined With MRI/Ultrasound Cognitive Fusion Targeted Biopsy for Prostate Cancer Diagnosis

Role: collaborator

NCT06968806Phase 3Recruiting

Study on Ketorolac for Improving Outcomes and Prognosis in Patients With Stanford Type A Aortic Dissection

Role: collaborator

NCT05818098Not ApplicableCompleted

Coronary Intravascular Lithotripsy System in Patients With Coronary Artery Calcification (VIGOUR)

Role: collaborator

NCT07731620Not ApplicableNot Yet Recruiting

Frontal vs Parietal Eminence Drainage for Chronic Subdural Hematoma

Role: collaborator

NCT07672210Recruiting

PregnAncy-Related Aortic DISsEction in China

Role: collaborator

NCT06538883Phase 4Completed

Sedation in ICU Patients With Mechanical Ventilation

Role: collaborator

NCT06711016Not ApplicableRecruiting

Target-directed Management of Cerebral Oxygenation in Patients After Receiving ECPR

Role: collaborator

NCT07446452Phase 2Recruiting

Disitamab Vedotin Plus Bevacizumab in HER2-Low Metastatic Breast Cancer After T-DXd Failure: A Phase II Study

Role: collaborator

NCT05230914Not ApplicableRecruiting

A Randomized Trial of Imaging Selection Modalities for Stroke Thrombectomy (NO-SELECT)

Role: collaborator

NCT07153744Phase 4Not Yet Recruiting

Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction

Role: collaborator

NCT07115550Not ApplicableNot Yet Recruiting

A Single-center, Single-arm, Phase II Clinical Study of Iparomlimab and Tuvonralimab Injection Combined With Regorafenib in the Treatment of Advanced Second-line or Above Hepatocellular Carcinoma

Role: lead

NCT07065435Phase 2Recruiting

RC48 Plus Bevacizumab or Pyrotinib in HER2-Positive Metastatic Breast Cancer After T-DXd Failure: A Phase II Study

Role: collaborator

NCT06841822Not ApplicableRecruiting

The Impact of Ultrasound-Guided Superficial and Deep Paravertebral Nerve Blocks at the Superior Costotransverse Ligament on Hemodynamics During the Induction Phase of Thoracoscopic Lung Lobectomy: A Multicenter, Double-Blind, Randomized Controlled Trial

Role: collaborator

NCT06936488Not ApplicableEnrolling By Invitation

A Prospective, Single Arm, Open Label, Phase II Clinical Study on the Efficacy and Safety of Ivonescimab (AK112) Combined With TAS-102 in the Treatment of Refractory MSS/pMMR Advanced Colorectal Cancer

Role: lead

NCT06762782Phase 2Recruiting

Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery

Role: collaborator

NCT06566807Phase 2Recruiting

Oxygen Study-Orelabrutinib Combined With Obinutuzumab(O2) for First-Line Treatment of Marginal Zone Lymphoma

Role: lead

NCT06504017Not ApplicableNot Yet Recruiting

FUS-TB VS COG-TB in Small Lesions of Prostate Cancer

Role: collaborator

NCT06445257Not ApplicableRecruiting

A Clinical Study Evaluating the Safety and Efficacy of ZRMT Regimen in the Treatment of PCNSL

Role: lead

NCT04660474Completed

Different Reperfusion Timing and Ventricular Arrhythmias in STEMI Patients

Role: collaborator

NCT06328179Not ApplicableRecruiting

Clinical Study Protocol for the Treatment of ND-AML and RR-AML With KMT2A Gene Abnormalities Using VHEA.

Role: lead